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Background
Chronic pain in response to tissue inflammation
(inflammatory pain) or nerve injury (neuropathic pain)
is often unresponsive to currently available treatments.
A large body of evidence indicates that production of
nitric oxide (NO) and activation of NO-sensitive gua-
nylyl cyclase (NO-GC) essentially contributes to the
processing of chronic pain. NO-GC is a heterodimer
consisting of one a subunit (a1 or a2) and one b1 sub-
unit and exists in two isoforms (NO-GC1 and NO-
GC2). However, the functional role of NO-GC1 and
NO-GC2 in pain processing remains poorly under-
stood. Here, we investigated the expression of NO-GC
isoforms in pain-relevant tissues (dorsal root ganglia
and the spinal cord) and characterized the nociceptive
behavior of mice lacking a1 or a2 in models of acute
nociceptive, inflammatory and neuropathic pain.
Conclusion
Our behavioral data point to different and partly con-
trary functions of NO-GC1 and NO-GC2 in the proces-
sing of inflammatory and neuropathic pain. The
expression of NO-GC isoforms in dorsal root ganglia
and the spinal cord is restricted to specific neuronal and
non-neuronal cell populations. It remains to be deter-
mined which targets mediate the pain-relevant effects of
NO-GC1 and NO-GC2.
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